| Title |
Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
|
|---|---|
| Published in |
SpringerPlus, February 2015
|
| DOI | 10.1186/s40064-015-0827-8 |
| Pubmed ID | |
| Authors |
Ann Butler Nattinger, Liliana E Pezzin, Emily L McGinley, John A Charlson, Tina W F Yen, Joan M Neuner |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 21 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 4 | 19% |
| Other | 3 | 14% |
| Researcher | 3 | 14% |
| Student > Ph. D. Student | 3 | 14% |
| Student > Bachelor | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 5 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 5 | 24% |
| Biochemistry, Genetics and Molecular Biology | 2 | 10% |
| Mathematics | 2 | 10% |
| Philosophy | 1 | 5% |
| Unspecified | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 8 | 38% |